Professional Documents
Culture Documents
1 NS
1 NS
1 NS
Irish Centre
for Fetal and
Neonatal
NEONATAL SEIZURE Alison O’Shea, Translational
DETECTION USING Gordon Lightbody, Research,
CONVOLUTIONAL NEURAL Geraldine Boylan, University
9/6/2021 NETWORK Andriy Temko College Cork
Neonatal
Seizures
Neonatal Seizures Clinical Clinical 2020,Vlume
9/6/2021 Guideline Butler,C. Guideline 1,pages1-15
Kaminiów,O.
Neonatal Seizures ,Kozak,S.& 2021,volume 8,
9/6/2021 Revisited Paprocka,J. Children page 155
THE MEDICAL
BULLETIN OF
SISLI ETFAL
Current Overview of Acar,D.B., HOSPITAL 2019 volu56 is
9/6/2021 Neonatal Convulsion Bülbül,A. & Uslu,S. 1 page 1-6
Hayder Al-
Momen, Majed
Kadhim The Tohoku
Muhammed, Ali 2018 年 246 Journal of
Neonatal Seizures in Iraq: Abdulhussein 巻 4 号 p. 245- Experimental
2021.9.10 Cause and Outcome Alshaheen 249 Medicine
UCSF Beniof's
2021.9.11 Neonatal seizures Organization
Carlotta Spagnoli,
Raffaele
Symptomatic seizures in Falsaperla,
preterm newborns: a Michela Deolmi,
review on clinical features Giovanni Corsello Italian Journal
2021.9.11 and prognosis & Francesco Pisani 2018 of Pediatrics
Annemiek M.W.
Loman
Henk J. ter Horst
Florise A.C.P. VOLUME 18,
Neonatal seizures: Lambrechtsen ISSUE 3, P360-
Aetiology by means of a Roelineke J. peadiatric 367, MAY 01,
2021.9.13 standardized work-up Lunsing neurology 2014
Dependent
Methodology Independent Variables Variable
Hypoxic Ischaemic
Encephalopathy (HIE)
Metabolic
disturbances,Infections Approach to
: M,Intracranial Management of
Haemorrhage, i neonatal seizure
The National Neonatal Perinatal Database (NNPD;
2002-03), which collected data from 18 tertiary
care units across the country, has reported an
incidence of 10.3 per 1000 live-births.2 The
incidence was found to increase with decreasing
gestation and birth weight - for example, preterm 1. Hypoxic-ischemic
infants had almost twice the incidence when encephalopathy
compared to term neonates (20.8 vs. 8.4 per 1000 (HIE),2. Metabolic
live-births) while very low birth weight infants had causes,3. Infections
more than 4-fold higher incidence (36.1 per 1000 4.Intracranial
live-births).2 hemorrhage: Management
hypoxic ischaemic
encephalopathy,
infarctions, intracranial
infection,
hypoglycaemia, inborn
errors of metabolism
and structural Antiepileptic
malformations. choice + monitorin
the
most common causes
of brain damage
manifested by seizures
include HIE, 2.
ischemic stroke,
The search strategy consisted of controlled ICH, 3. transient
vocabulary and keywords. The following metabolic and
databases were searched: PubMed, Medline and electrolyte
Google Scholar. The main search concept disturbances, 4.
was to combine “neonatal seizures” with related systemic or central
terms, such as “pathophysiology”, “etiol ogy”, nervous system
“genetic(s)”, “symptoms”, “diagnosis”, (CNS) infections
“treatment” and “outcomes”.English language [2,20,21]. 5. The causes
papers published within the previous 10 years also include congenital
were malformations of the
considered for this review. The entire process of CNS
searching relevant and genetic epilepsy
papers lasted from April 2020 to October 2020, syndromes (e.g.,
with numerous subsequent updates on benign familial
the latest scientific reports. Titles, abstracts and neonatal seizures or
full-text articles were screened against inborn errors
the inclusion criteria by two reviewers. N of metabolism) [2 . Management
Hypoxic ischemic
encephalopathy
(HIE)38% 2.ischemic
stroke (18%), 3.
intracranial
hemorrhage (12%),
epilepsy (6%), central
nervous system
infection (4%), and
transient metabolic
disorders (4%), Treatment
hypoxic-ischemic
encephalopathy
All full-term born neonates from January 2002 till (HIE),metabolic or
September 2009 with neonatal seizures, admitted electrolyte
to our neonatal intensive care unit were included disorders,intracranial
(n = 221). Aetiology was investigated by means of a hemorrhage ,ischemic
standardized aetiologic work-up. infarction ,intracranial aetiologies of
Results infections neonatal seizures
Findings of research Link / URL
good folloup
The
key to therapeutic success seems
to be the immediate management
of the cause and the
introduction of appropriate
treatment, which will reduce
adverse long-term effects and
improve the results. Therefore, in
certain clinical situations,
treatment should be carried out
simultaneously with the initial
diagnosis. The reports on the
approach to the diagnosis or
Children 2021, 8, 155 14 of 17
treatment of seizures and the
results obtained with the use of
various therapeutic methods
allow for the exchange of
experience among clinicians and
. Acute Intervention 2.Treatment of Neontal Epilepsy constitute a broad base of
3.Outcomes practical knowledge.
Neonatal convulsions should be
stopped quickly and the
etiological cause should be
determined. The treatment is
primarily directed to the
etiological cause. Phenobarbital
is still the drug used as first-line
treatment in infants who
require an anticonvulsant drug.
Levetiracetam and pheny toin are
commonly used as second-line
anticonvulsant
drugs. Current guidelines for
anticonvulsant drugs used
in the newborn period still do not
appear to be adequate.
Therefore, large-scale, well-
planned studies of anticonvul sant
drugs that can be used in
neonatal convulsions are
Anticonvulsant Drugs 2. Treatment-resistant Convulsion required
https://bmcpediatr.biomedcentral.com/articles/10.1186/s12
Experimental data regarding the potential efficacy of agents
such as bumetanide, topiramate, and levetiracetam are
encouraging, but the duration of use of these agents may be
limited by safety concerns related to their effects on long-term
brain development.,Animal model trials and human studies
must be aligned to understand how safety and efficacy data
from rodent and non-human primates predict human responses.
A number of early-life seizure models exist in which there are
indeed long-term effects on learning, and these could also be
employed to address the effects of treatment on brain and
cognitive development. Clinical therapeutic trials in neonates
would be greatly improved if there were accurate biomarkers of
acute and chronic therapeutic efficacy, yet none exist other than
the EEG.,Incorporation of continuous EEG monitoring into
clinical studies of neonatal seizure therapy will be essential.
Seizure cessation is an important therapeutic goal, yet improved
neurodevelopmental outcome is clearly of critical importance. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818833/
https://www.ucsfbenioffchildrens.org/conditions/neonatal-seizures
In the future, research should be addressed to identify a
customized treatment for preterm newborns, considering their
pharmacokinetic and pharmacodynamic changes and brain
developmental stages.
/https://ijponline.biomedcentral.com/articles/10.1186/s13052-
018-0573-y
https://www.msdmanuals.com/
professional/pediatrics/
neurologic-disorders-in-children/
neonatal-seizure-disorders
https://www.ejpn-journal.com/article/S1090-3798(14)00037